[EN] BICYCLOHETEROARYLAMINE COMPOUNDS AS ION CHANNEL LIGANDS AND USES THEREOF [FR] COMPOSES BICYCLOHETEROARYLAMINE COMME LIGANDS DE CANAUX IONIQUES ET UTILISATIONS DESDITS COMPOSES
[EN] BICYCLOHETEROARYLAMINE COMPOUNDS AS ION CHANNEL LIGANDS AND USES THEREOF [FR] COMPOSES BICYCLOHETEROARYLAMINE COMME LIGANDS DE CANAUX IONIQUES ET UTILISATIONS DESDITS COMPOSES
Triphenylphosphine derivative, production process therefor, palladium complex thereof, and process for producing biaryl derivative
申请人:——
公开号:US20030065208A1
公开(公告)日:2003-04-03
Provided are a novel triphenyl phosphine derivative synthesized from a triphenylphosphine and a hydroxy-containing lactone; a palladium and a nickel complexes comprising the derivative as a ligand; and a process for preparing a biaryl derivative using the complex as a catalyst. A product can be easily separated from a catalyst or a phosphorus compound, and biaryl derivative can be synthesized in a higher yield, by using the complex of the present invention as a catalyst.
TRIPHENYLPHOSPHINE DERIVATIVE, PRODUCTION PROCESS THEREFOR, PALLADIUM COMPLEX THEREOF, AND PROCESS FOR PRODUCING BIARYL DERIVATIVE
申请人:Mitsubishi Rayon Co., Ltd.
公开号:EP1270582A1
公开(公告)日:2003-01-02
Provided are a novel triphenyl phosphine derivative synthesized from a triphenylphosphine and a hydroxy-containing lactone; a palladium and a nickel complexes comprising the derivative as a ligand; and a process for preparing a biaryl derivative using the complex as a catalyst. A product can be easily separated from a catalyst or a phosphorus compound, and biaryl derivative can be synthesized in a higher yield, by using the complex of the present invention as a catalyst.
TRIPHENYLPHOSPHINE DERIVATIVES, PALLADIUM OR NICKEL COMPLEXES THEREOF, AND PROCESS FOR PREPARING BIARYL DERIVATIVES
申请人:MITSUBISHI RAYON CO., LTD.
公开号:EP1270582B1
公开(公告)日:2006-08-30
N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2
申请人:NOVARTIS AG
公开号:US20210371429A1
公开(公告)日:2021-12-02
The present invention relates to compounds of formula I:
in which p, q, Y
1
, Y
2
, R
1
, R
2a
, R
2b
, R
3a
, R
3b
, R
4a
, R
4b
, R
5a
, R
5b
, R
7
and R
8
are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.